Secondary analysis of FAVOR III Europe, 1,191 vessels: in-procedure vs core laboratory QFR agreement was modest (diagnostic agreement 72%, correlation 0.58); 8% of in-procedure analyses were rated poor or very poor.
Secondary analysisn = 1,191 vessels
Kristensen et al. Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study